BPA for cortrophin

Ended Awarded Last action

Contract number
36E79722A0030
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$595,337.50
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs (VA) National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA) to Anip Acquisition Co, doing business as Ani Pharmaceuticals, for the acquisition of corticotropin. This $595,337.50 BPA has a period of performance through June 1, 2024, and was established under Ani Pharmaceuticals' existing Federal Supply Schedule (FSS) contract with the VA for "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." Additionally, the VA awarded Ani Pharmaceuticals a separate single-award BPA worth $120,425.60 against the Pharmaceuticals and Drugs GSA schedule for the procurement of corticotropin gel through July 14, 2022. These BPAs facilitate the VA's efficient acquisition of corticotropin and corticotropin gel for treating various medical conditions at its healthcare facilities nationwide, leveraging the streamlined ordering processes and pre-negotiated pricing provided by the FSS and BPA contract vehicles.

Anip Acquisition Co, through its Ani Pharmaceuticals division, is an integrated specialty pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals, with a focus on controlled substances, anti-cancer drugs, hormones and steroids, and complex formulations. Ani Pharmaceuticals is registered on SAM.gov as a self-certified small disadvantaged business and for-profit organization.

Transactions

Action Obligated Date
Legal Contract Cancellation P00003 · This modification is issued to cancel BPA 36E79722A0030 in its entirety. $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 on BPA 36E79722A0030. $0
Supplemental Agreement for work within scope P00001 · 2023 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79722A0030?

36E79722A0030 was awarded to Anip Acquisition Co by National Acquisition Center (Headquarters) on September 30, 2022.

How much is contract 36E79722A0030 worth?

36E79722A0030's own ceiling is $595,338.

Who can order from contract 36E79722A0030?

36E79722A0030 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79722A0030 under another contract?

Yes. 36E79722A0030 is a blanket purchase agreement under 36F79722D0123, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79722A0030 competed?

The extent of competition for 36E79722A0030 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV